← Mechanisms of action
EPO
SINGLE PROTEINHomo sapiens
Preferred name: Erythropoietin ChEMBL ↗
Linked proteins
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| heme iron polypeptide | Activator | experimental | Peptide | EPO activator |
| amg 114 | Supplementation | experimental | Recombinant protein | EPO supplementation |
| ara 290 | Supplementation | experimental | Peptide | EPO supplementation |
| ara290 | Supplementation | experimental | Peptide | EPO supplementation |
| beta erythropoietin | Supplementation | experimental | Recombinant protein | EPO supplementation |
| darbepoetin alfa (aranesp) | Supplementation | approved | Recombinant protein | EPO supplementation |
| epoetin (Epogen) | Supplementation | approved | Recombinant protein | EPO supplementation |
| lu aa24493 | Supplementation | experimental | Recombinant protein | EPO supplementation |
| mdgn201 | Supplementation | experimental | Gene therapy | EPO supplementation |
| methoxy polyethylene glycol-epoetin beta (Mircera) | Supplementation | approved | Recombinant protein | EPO supplementation |
| peginesatide (Omontys) | Supplementation | approved | Peptide | EPO supplementation |
| pegol-sihematide | Supplementation | experimental | Peptide | EPO supplementation |
| pegylated erythropoeitin | Supplementation | experimental | Recombinant protein | EPO supplementation |
| rHSA/EPO | Supplementation | experimental | Recombinant protein | EPO supplementation |